Tip
- Pharmacokinetics (PK): What the body does to the drug.
- Focus: Movement of drug into, through, and out of the body.
- Determines the concentration of the drug at its site of action over time.
- Pharmacodynamics (PD): What the drug does to the body.
- Focus: Mechanism of action and physiological effects.
- Determines the intensity and duration of the clinical effect.
Drug tolerance
1. Acquired Pharmacokinetic Tolerance
- Mechanism:
- ADME: ↓ Absorption, ↑ Distribution, or ↑ Metabolism & Excretion (e.g., enzyme induction)
- ↓ Plasma drug concentration relative to naïve state
- Example:
- Rifampin (CYP3A4 inducer) accelerates the metabolism of warfarin.
- Carbamazepine induces its own metabolism after repeated dosing.
2. Acquired Pharmacodynamic Tolerance
- Mechanism:
- ↓ Cellular response to drug (e.g., receptor downregulation)
- Unchanged plasma drug concentration relative to naïve state
- Example:
- Chronic opioid use: ↓ expression & responsivity of μ receptor systems.
- Frequent albuterol rescue inhaler: ↓ expression of airway β2 receptors.
3. Innate Tolerance
- Mechanism:
- Genetic (e.g., polymorphisms) & epigenetic (e.g., DNA methylation) differences
- Leads to pharmacokinetic or pharmacodynamic tolerance
- Tolerance apparent from first dose
- Example:
- Slow metabolizer CYP2C19 allele: ↓ clopidogrel activation (↓ antiplatelet effect)
- Slow metabolizer CYP2D6 allele: ↓ codeine conversion to morphine (↓ analgesic effect)
4. Behavioral (Functional) Tolerance
- Mechanism:
- Ability to compensate for drug-induced impairment through learning & practice
- Example:
- Maintaining appearance & mannerisms to appear non-intoxicated at work
Tachyphylaxis
- Definition
- Acute, sudden decrease in response to a drug after its administration.
- Tachy- (tachys) = Rapid or Fast (e.g., Tachycardia).
- -phylaxis (phylax) = Protection or Guarding (e.g., Prophylaxis, Anaphylaxis).
- Literal translation: “Rapid protection.”
- Distinguish from tolerance, which is a more gradual loss of response over time (days/weeks).
- Acute, sudden decrease in response to a drug after its administration.
- Pathophysiology / Mechanism
- Receptor Desensitization/Internalization: Receptors become unresponsive to the ligand or are removed from the cell surface.
- Depletion of Intracellular Mediators: Drugs that act indirectly (e.g., by releasing stored neurotransmitters) fail when the stored supply is exhausted.
- Classic USMLE Examples
- Nitrates (Nitroglycerin, Isosorbide dinitrate)
- Mechanism: Often attributed to depletion of intracellular sulfhydryl (-SH) groups or generation of free radicals inhibiting NO signaling.
- Management: Requires a “Nitrate-free interval” of 8–12 hours daily (usually at night) to restore sensitivity.
- “Monday Disease”: Industrial workers exposed to nitrates develop headaches (vasodilation) on Mondays due to loss of tolerance over the weekend; symptoms disappear later in the week due to tachyphylaxis.
- Nasal Decongestants (Oxymetazoline, Phenylephrine)
- Condition: Rhinitis Medicamentosa (Rebound Congestion).
- Mechanism: Alpha-adrenergic receptor downregulation and desensitization.
- Clinical: Severe congestion returns after stopping the drug if used for >3 days.
- Indirect Sympathomimetics (Ephedrine, Tyramine, Amphetamines)
- Mechanism: These drugs displace norepinephrine (NE) from presynaptic vesicles into the synapse.
- Effect: Tachyphylaxis occurs when the presynaptic stored pool of NE is depleted; additional drug doses cannot release more NE.
- Local Anesthetics
- Can occur with repeated injections into the same site, leading to ↓ duration or intensity of analgesia.
- Nitrates (Nitroglycerin, Isosorbide dinitrate)